Diagnosis and detection of myocardial injury in active cardiac sarcoidosis: Significance of myocardial fatty acid metabolism and myocardial perfusion mismatch

Circulation Journal

Volumn 79, Issue 12, 2015, Pages 2669-2676

  Momose, Mitsuru ^a   Fukushima, Kenji ^a   Kondo, Chisato ^a   Serizawa, Naoki ^a   Suzuki, Atsushi ^a   Abe, Koichiro ^a   Hagiwara, Nobuhisa ^a   Sakai, Shuji ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Cardiac sarcoidosis; Inflammation; Metabolic imaging; Myocardial perfusion; Positron emission tomography

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; IODOFILTIC ACID I 123; THALLIUM 201; FATTY ACID; IODOBENZENE; IODOFILTIC ACID;

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MAGNETIC RESONANCE; COMPLETE HEART BLOCK; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE ASSOCIATION; FATTY ACID METABOLISM; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE INJURY; HEART MUSCLE PERFUSION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMAGE ANALYSIS; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SARCOIDOSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; AGED; CARDIAC MUSCLE; CARDIOMYOPATHIES; CLINICAL TRIAL; METABOLISM; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY;

ADULT; AGED; CARDIOMYOPATHIES; FATTY ACIDS; FEMALE; HUMANS; IODOBENZENES; MALE; MIDDLE AGED; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; SARCOIDOSIS;

EID: 84964261693     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-15-0681     Document Type: Article

References (28)

1. Dubrey SW, Falk RH. Diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis 2010; 52: 336 - 346.
2. Uemura A, Morimoto S, Hiramitsu S, Kato Y, Ito T, Hishida H. Histologic diagnostic rate of cardiac sarcoidosis: Evaluation of endomyocardial biopsies. Am Heart J 1999; 138: 299 - 302.
3. Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014; 11: 1305 - 1323.
4. Miyagawa M, Yokoyama R, Nishiyama Y, Ogimoto A, Higaki J, Mochizuki T. Positron emission tomography-computed tomography for imaging of inflammatory cardiovascular diseases. Circ J 2014; 78: 1302 - 1310.
5. 18F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. Eur J Nucl Med Mol Imaging 2011; 38: 1773 - 1783.
6. Okumura W, Iwasaki T, Toyama T, Iso T, Arai M, Oriuchi N, et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 2004; 45: 1989 - 1998.
7. Schatka I, Bengel FM. Advanced imaging of cardiac sarcoidosis. J Nucl Med 2014; 55: 99 - 106.
8. Knapp FF Jr, Franken P, Kropp J. Cardiac SPECT with iodine- 123-labeled fatty acids: Evaluation of myocardial viability with BMIPP. J Nucl Med 1995; 36: 1022 - 1030.
9. 99mTc-tetrofosmin SPECT and coronary angiography. Circ J 2004; 68: 547 - 552.
10. Yoshinaga K, Naya M, Shiga T, Suzuki E, Tamaki N. Ischaemic memory imaging using metabolic radiopharmaceuticals: Overview of clinical settings and ongoing investigations. Eur J Nucl Med Mol Imaging 2014; 41: 384 - 393.
11. 123I-beta-methyl-piodophenyl- penta-decanoic acid myocardial single-photon emission computed tomography images in patients with anterior acute myocardial infarction. Circ J 2013; 77: 137 - 145.
12. Kaminaga T, Takeshita T, Yamauchi T, Kawamura H, Yasuda M. The role of iodine-123-labeled 15-(p-iodophenyl)-3R,S-methylpentadecanoic acid scintigraphy in the detection of local myocardial involvement of sarcoidosis. Int J Cardiol 2004; 94: 99 - 103.
13. Brown ML, Reeder G, Unni KK, Mullany C. Intraoperative diagnosis of isolated cardiac sarcoid. Heart Lung Circ 2007; 16: 315 - 317.
14. Chang TI, Chi NH, Chou NK, Tsao CI, Yu HY, Chen YS, et al. Isolated cardiac sarcoidosis in heart transplantation. Transplant Proc 2012; 44: 903 - 906.
15. Chinitz JS, Inra LA, Stein KM, Weinsaft JW. Isolated cardiac sarcoid in a patient with unexplained syncope. J Cardiovasc Electrophysiol 2010; 21: 333.
16. Kandolin R, Lehtonen J, Graner M, Schildt J, Salmenkivi K, Kivisto SM, et al. Diagnosing isolated cardiac sarcoidosis. J Intern Med 2011; 270: 461 - 468.
17. 18-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis. J Nucl Cardiol 2013; 20: 297 - 306.
18. 123I-betamethyl-p-iodophenylpentadecanoic acid single-photon emission computed tomography in diabetic patients with suspected ischemic heart disease. Circ J 2012; 76: 2633 - 2639.
19. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002; 105: 539 - 542.
20. Watanabe E, Kimura F, Nakajima T, Hiroe M, Kasai Y, Nagata M, et al. Late gadolinium enhancement in cardiac sarcoidosis: Characteristic magnetic resonance findings and relationship with left ventricular function. J Thorac Imaging 2013; 28: 60 - 66.
21. 18F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations. Ann Nucl Med 2014; 28: 393 - 403.
22. Galati G, Leone O, Rapezzi C. The difficult diagnosis of isolated cardiac sarcoidosis: Usefulness of an integrated MRI and PET approach. Heart 2014; 100: 89 - 90.
23. Lurz P, Eitel I, Adam J, Steiner J, Grothoff M, Desch S, et al. Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. JACC Cardiovasc Imaging 2012; 5: 513 - 524.
24. Matsui Y, Iwai K, Tachibana T, Fruie T, Shigematsu N, Izumi T, et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann NY Acad Sci 1976; 278: 455 - 469.
25. Soussan M, Brillet PY, Nunes H, Pop G, Ouvrier MJ, Naggara N, et al. Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis. J Nucl Cardiol 2013; 20: 120 - 127.
26. 18F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet. J Cardiol 2013; 62: 314 - 319.
27. 18F-fluorodeoxyglucose uptake by PET/CT for detection of cardiac sarcoidosis. Int J Cardiol 2015; 195: 180 - 187.
28. Shenthar J, Milasinovic G, Al Fagih A, Gotte M, Engel G, Wolff S, et al. MRI scanning in patients with new and existing CapSureFix Novus 5076 pacemaker leads: Randomized trial results. Heart Rhythm 2015; 12: 759 - 765.